Dr. Phillips is an experienced pharmaceutical executive with over 28 years of global leadership and clinical development experience. In his most recent role as CEO, for Health Decisions Inc., he was responsible for leading the development and execution of a strategic business plan that enabled year on year growth of more than 40%, over a 4-year period, culminating in a successful exit in July 2021. Dr. Phillips has also provided executive oversight and led operational delivery on more than 200 regional and global clinical development projects in all major therapeutic areas, across all phases of drug development and held executive positions for companies such as Premier Research, ICON, Boehringer Ingelheim and Array Biopharma line. He has overseen 15 successful NDAs and PMA approvals in the last 10 years. Dr. Phillips currently provides strategic consulting services to life sciences companies. He holds a BSc (Hons) in Biochemistry from Liverpool University and a D.Phil. in Clinical Biochemistry from the University of Oxford.